Mainz Biomed N.V. (MYNZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 894 | 896 | 530 | 577 | 494 |
| Cost of Goods | 319 | 386 | 348 | 400 | 371 |
| Gross Profit | 575 | 510 | 182 | 178 | 123 |
| Operating Expenses | 19,589 | 27,540 | 26,974 | 10,302 | 1,167 |
| Operating Income | -18,695 | -26,645 | -26,444 | -9,725 | -674 |
| Interest Expense | 1,075 | 810 | 0 | 199 | 176 |
| Other Income | -1,880 | 1,159 | 57 | -1,766 | 263 |
| Pre-tax Income | -21,651 | -26,296 | -26,387 | -11,690 | -587 |
| Net Income Continuous | -21,651 | -26,296 | -26,387 | -11,690 | -587 |
| Net Income | $-21,651 | $-26,296 | $-26,387 | $-11,690 | $-587 |
| EPS Basic Total Ops | -22.36 | -64.76 | -74.40 | -64.80 | -4.00 |
| EPS Basic Continuous Ops | -22.36 | -64.76 | -74.56 | -64.85 | -4.19 |
| EPS Diluted Total Ops | -22.36 | -64.76 | -74.40 | -64.80 | -4.00 |
| EPS Diluted Continuous Ops | -22.36 | -64.76 | -74.56 | -64.85 | -4.19 |
| EPS Diluted Before Non-Recurring Items | -22.36 | -64.80 | -74.40 | -64.80 | N/A |
| EBITDA(a) | $-17,678 | $-25,778 | $-26,064 | $-9,655 | $-613 |